ClinicalTrials.Veeva

Menu

Evaluation of the Response to Hypoxia at Rest and During Exercise in a Healthy Subject After a Cryostimulation Exposure (CRYOX)

P

Poitiers University Hospital

Status

Not yet enrolling

Conditions

Metabolism
Cryostimulation
Adaptation
Hypoxia
Autonomic Nervous System
Exercise

Treatments

Other: Cryostimulation

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Many information is available regarding human adaptations to cold or hypoxia. Adaptations to these environments and physical exercise constitute responses to physiological stress aimed at amplifying the organism's reactions and improving its performance. However, studies conducted so far to understand these adaptations and their underlying mechanisms have been organized in a dissociated manner, with each study focusing on only one of these specific situations (cold, hypoxia, or exercise). Understanding cross-adaptations is crucial, as human beings are often simultaneously exposed to several of these stimuli, and understanding this cross-exposure can be considered a prerequisite for pre-acclimatization strategies to these different environments.

Cross-adaptations has been defined as follows: "It simply involves considering that long-term exposure (either continuous or intermittent) to a given unfavorable environment not only increases tolerance to that particular environment but also leads to gains or losses of tolerance to other unfavorable factors that the adapted organism had never encountered before." When specifically examining cross-adaptations to cold and hypoxia, only one study focusing on the human model is available. The lack of perspectives and positions regarding the results calls for further investigations.

The main objective of this study is to assess the effect of repeated exposures to cryostimulation on the variation of the respiratory exchange ratio in hypoxia during exercise.

Enrollment

35 estimated patients

Sex

Male

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Having a high level of physical activity according to the criteria of the World Health Organization, assessed using the Global Physical Activity Questionnaire (GPAQ);
  • No exposure to cryostimulation or hypoxia (FiO2 13.5%, equivalent to an altitude of 3500 m) in the last 90 days;
  • No planned sports competition during the 4 weeks of the protocol;
  • Maintaining a stable physical activity level (regular training, without interruption or specific competition, including sports training programs) anticipated for 4 weeks;
  • No history of respiratory conditions (asthma, respiratory allergies, exercise-induced asthma, exertional dyspnea);
  • Absence of any chronic medical condition;
  • No ongoing medication treatments;
  • Covered by a French Social Security;
  • Informed consent, signed by the subject after clear and fair information about the study.

Exclusion criteria

  • Subject under treatment;
  • Simultaneous participation in another clinical research study;
  • Individuals with enhanced protection, namely minors, individuals deprived of liberty by judicial or administrative decision, persons staying in a healthcare or social facility, adults under legal protection, and finally, patients in emergency situations;
  • Subject presenting a contraindication to hypoxia and/or cryostimulation.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

35 participants in 2 patient groups

Control Group
No Intervention group
Description:
Participants will not undergo cryostimulation exposure but will only receive 2 1-hour hypoxia sessions at FiO2 13.5% for 1 hour, at 2-week interval
Cryostimulation Group
Experimental group
Description:
Participants will be exposed to cryostimulation (-50°C, forced ventilation for 3 minutes) during 20 sessions over 2 weeks and will undergo 2 hypoxia sessions at FiO2 13.5% for 1 hour, at 2-week interval
Treatment:
Other: Cryostimulation

Trial contacts and locations

2

Loading...

Central trial contact

Corentin FAUCHER, MSc; Nadia TEIXEIRA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems